Page 79 - General Catalyst News Today

The biggest rounds of recent biotech financings are from startups raising money to advance their research to the clinic. Here’s a look back at funding rounds from companies such as Abdera Therapeutics, Complement Therapeutics, and Enveda Biosciences.

Ahead of National Infertility Awareness Week, new research provides blueprint for better fertility & family-building supportNEW YORK, April 20, 20...

Health tech products that leverage AI have the most market longevity.

Memora Health recently raised $30 million in funding. The company's platform automates touch points for complex care patients through text messaging-based programs. Some of Memora's customers include Mayo Clinic, Penn Medicine, Northwell Health and Boston Medical Center.

At HIMSS23, Holly Maloney, managing director of General Catalyst, discussed the promise and challenge of using artificial intelligence in healthcare.

/PRNewswire/ -- Prosimo, today unveiled new innovations transforming how enterprises design, build, troubleshoot, and manage single and multi cloud networking...

The funds will be used to scale the company's AI-enabled care navigation platform with healthcare systems.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

/PRNewswire/ -- Memora Health, the leading intelligent care enablement platform, today announced a strategic investment of $30 million led by General Catalyst...

Some health systems are working with venture capital firms to invest in innovation. But experts stress the risks related to ethical issues.